Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 591 JPY -6.49% Market Closed
Market Cap: 234.8B JPY
Have any thoughts about
Sumitomo Pharma Co Ltd?
Write Note

Sumitomo Pharma Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sumitomo Pharma Co Ltd
Operating Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Sumitomo Pharma Co Ltd
TSE:4506
Operating Income
-ÂĄ306.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
ÂĄ403B
CAGR 3-Years
-17%
CAGR 5-Years
13%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
ÂĄ260.5B
CAGR 3-Years
51%
CAGR 5-Years
19%
CAGR 10-Years
7%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
ÂĄ353.6B
CAGR 3-Years
19%
CAGR 5-Years
33%
CAGR 10-Years
5%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
ÂĄ540.2B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
Operating Income
ÂĄ130.6B
CAGR 3-Years
-1%
CAGR 5-Years
-13%
CAGR 10-Years
-1%

See Also

What is Sumitomo Pharma Co Ltd's Operating Income?
Operating Income
-306.4B JPY

Based on the financial report for Jun 30, 2024, Sumitomo Pharma Co Ltd's Operating Income amounts to -306.4B JPY.

What is Sumitomo Pharma Co Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
-192%

Over the last year, the Operating Income growth was -192%.

Back to Top